IOVA — IOVANCE BIOTHERAPEUTICS INC

Ownership history in NATIXIS  ·  6 quarters on record

This page tracks every 13F SEC filing in which NATIXIS reported a position in IOVANCE BIOTHERAPEUTICS INC (IOVA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.01% (2022 Q1)
Avg. % of fund
0.0%
First filed
2021 Q2
Last filed
2025 Q3
Quarters held
6
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 20,479 -23,801 -53.8% 0.00% $44K $2.17
2025 Q2 ADDED 44,280 +28,291 +176.9% 0.00% $76K $1.72
2023 Q2 ADDED 15,989 +14,949 +1437.4% 0.00% $113K $7.04
2023 Q1 REDUCED 1,040 -142,000 -99.3% 0.00% $6K $6.11
2 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    IOVA price (monthly, adj. close)

Other funds also holding IOVA

As of 2025 Q4 — sorted by position size

MHR FUND MANAGEMENT LLC 3Y 7Y 6.81% B Group, Inc. 3.02% Palo Alto Investors LP 3Y 7Y 2.7% Orion Investment Co 1.54% Invenomic Capital Management LP 3Y 1.52% CM Management, LLC 3Y 0.92% Parametrica Management Ltd 3Y 7Y 0.82% Long Focus Capital Management, LLC 3Y 0.62% Rhenman & Partners Asset Management AB 3Y 7Y 0.41% Mirador Capital Partners LP 3Y 7Y 0.39%
← Back to NATIXIS Holdings